The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
Clinical trial NCT05145296 · TERMINATED
Trial details
- NCT number
- NCT05145296
- Sponsor
- University Hospital, Grenoble
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2024-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.